Search

Search Results

• 

  Emergence of acute promyelocytic leukemia in a patient with granulomatosis with polyangiitis during treatment with cyclophosphamide: a rare case report

  F.I. Gorial, N.I. Awadh, N.W. Shaheen, A. Dheyaa, Z.H. Ali, N. Wajdi

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1593

  1660

  PDF: 419

• PO:37:260 | Mepolizumab in the treatment of patients with eosinophilic granulomatosis with polyangiitis: real-life experience from a single-center cohort Eleonora Bruschi¹, Fabrizio Angeli¹, Alessandro Belotti Masserini¹, Stefania Bertocchi¹, Silvia Breda¹, Elide Lupi¹, Valeria Rossi¹, Tania Ubiali¹, Massimiliano Limonta¹ | ¹ASST Papa Giovanni XXIII Bergamo Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2220

  176

• PO:17:259 | Anifrolumab: a new management of SLE Giorgia Montozzi¹, Chiara Cocco¹, Ramona Santangeli¹, Lucia Gamba¹, Paola Fioretti¹, Letizia Curina¹, Chiara Guidoni¹, Edoardo Cipolletta³, Gianluca Moroncini² | ¹Scuola di Specializzazione in Medicina Interna, Università Politecnica delle Marche Ancona, Italy; ²Department of Clinical and Molecular Sciences, Università Politecnica delle Marche Ancona, Italy; ³Rheumatology Unit, Department of Clinical and Molecular Sciences , Università Politecnica delle Marche Ancona, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2336

  83
• 

  Coexisting rheumatoid arthritis and sickle cell disease: case series and literature review

  Abdallah Alqethami, Sabri Alsaeedi, Samera Felemban, Abdulelah Qadi

  07-01-2025

  https://doi.org/10.4081/reumatismo.2025.1682

  2577

  PDF: 500
• 

  The association between serum prolactin levels and interleukin-6 and systemic lupus erythematosus activity

  W.A. Wan Asyraf, M.S. Mohd Shahrir, W. Asrul, A.W. Norasyikin, O. Hanita, W.Y. Kong, M.T. Azmi

  241-250

  20-12-2018

  https://doi.org/10.4081/reumatismo.2018.1075

  1955

  PDF: 1195

• PO:35:220 | IgG anti-pentraxin 3 autoantibodies distinguish eosinophilic granulomatosis with polyangiitis from severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps Eleonora Fiorin¹, Anna Ghirardello¹, Federica Davanzo¹, Luca Iorio¹, Marta Codirenzi¹, Roberta Prevedello¹, Roberto Padoan¹, Andrea Doria¹. | ¹Università di Padova, Dipartimento di Medicina DIMED, UOC di Reumatologia, Padova, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2087

  152

• CO:12:4 | Predicting 12-month clinical relapse in Takayasu arteritis using ^[18F]FDG PET and convolutional neural networks Alessandro Tomelleri¹, Carolina Bezzi², Sara Resta², Corrado Campochiaro¹, Federico Fallanca², Elena Baldissera¹, Samuele Ghezzo², Nicola Farina¹, Arturo Chiti², Paola Mapelli², Marco Matucci-Cerinic¹, Maria Picchio², Lorenzo Dagna¹. | ¹IRCCS Ospedale San Raffaele, Unità di Immunologia Reumatologia Allergologia e Malattie Rare, Milano; ²IRCCS Ospedale San Raffaele, Unità di Medicina Nucleare, Milano, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.1998

  209
• 

  Anti-tumor necrosis factor α: originators versus biosimilars, comparison in clinical response assessment in a multicenter cohort of patients with inflammatory arthropathies

  C. Gioia, A. Picchianti Diamanti, R. Perricone, M.S. Chimenti, A. Afeltra, L. Navarini, A. Migliore, U. Massafra, V. Bruzzese, P. Scolieri, C. Meschini, M. Paroli, R. Caccavale, P. Scapato, R. Scrivo, F. Conti, B. Laganà, M. Di Franco

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1602

  2229

  PDF: 557

• Polyarteritis nodosa cutanea: a case report

  P. Bravi, P. Martini

  108-111

  https://doi.org/10.4081/reumatismo.2003.108

  1005

  PDF: 4226

• PO:37:267 | Mimickers of polyarteritis nodosa: a case of segmental arteriolar mediolysis Filippo Santoro¹, Caterina Vacchi², Giulia Cassone², Maria Grazia Malandra¹, Dilia Giuggioli^1|2 | ¹UOSD Reumatologia, Ospedale San Camillo De Lellis, Rieti; ²UOC Igiene e Sanità Pubblica, ASL Rieti; ³Direzione Sanitaria, ASL Rieti, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2221

  199

• PO:16:234 | Differential efficacy of induction treatments for lupus nephritis at onset and relapses: an observational study Giuseppe Alvise Ramirez^1|2, Gabriele D Gallina¹, Chiara Calabrese^1|2, Serena Nannipieri^1|2, Marta Calatroni^3|4, Francesco Reggiani^3|4, Giovanni Benanti¹, Enrica Paola Bozzolo¹, Raffaele Ceniccola², Luca Moroni^1|2, Marco Matucci-Cerinic^1|2, Gabriella Moroni^3|4, Lorenzo Dagna^1|2 | ¹IRCCS San Raffaele Hospital, Unit of Immunology, Rheumatology, Allergy and Rare Diseases Milan, Italy; ²Vita- Salute San Raffaele University Milan, Italy; ³IRCCS Humanitas Research Hospital, Nephrology and Dialysis Division Rozzano, Milan, Italy; ⁴Humanitas University, Department of Biomedical Sciences Rozzano, Milan, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2334

  69

• Long-term evaluation of infliximab in the treatment of persistently active juvenile idiopathic arthritis refractory to conventional therapy

  G. De Marco, V. Gerloni, I. Pontikaki, A. Lurati, B. Teruzzi, A. Salmaso, E. Valcamonica, M. Gattinara, F. Fantini

  50-56

  https://doi.org/10.4081/reumatismo.2007.50

  1304

  PDF: 906

• PO:17:255 | Efficacy and safety of voclosporin in the management of lupus nephritis: a case series Alessandra Oliva¹, Elisabetta Chessa², Marta Paola Pireddu¹, Marianna Salis¹, Giulia Rizzo¹, Fabio Congiu¹, Elena Ragusa¹, Antonello Pani^3|4, Alberto Cauli^1|2, Nicola Lepori^3|4, Matteo Piga^1|2 | ¹UOC Reumatologia, Dipartimento di Scienze Mediche e Salute Pubblica, Università degli Studi di Cagliari; ²UOC Reumatologia, AOU Cagliari; ³SC Nefrologia e Dialisi, Università degli Studi di Cagliari; ⁴SC Nefrologia e Dialisi, Azienda Ospedaliera Brotzu, Cagliari, Italy

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2169

  177

• PO:23:052 | Muscular and myocardial involvement in antisynthetase syndrome: a retrospective real-life study Giulia Buonsante^1|2|3, Giacomo De Luca^1|2|3, Veronica Batani^1|2, Daniele Scaramuzzi^1|2|3, Lorenzo Dagna^1|2|3, Marco Matucci-Cerinic^1|2|3, Corrado Campochiaro^1|2|3. | ¹Unit of Immunology, Rheumatology, Allergy and Rare Diseases UNIRAR, IRCCS San Raffaele Hospital, Milano, Italy; ²Inflammation, Fibrosis and aging Initiative INFLAGE, IRCCS San Raffaele Hospital, Milano, Italy; ³Vita-Salute San Raffaele University, Milan, Italy, Milano, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2056

  195

• Long term outcome of treatment of diffuse proliferative glomerulonephritis with pulse steroids and short course pulse cyclophosphamide

  C. Tani, M. Mosca, A. d'Ascanio, R. Neri, A. Tavoni, L. Carli, S. Bombardieri

  215-220

  https://doi.org/10.4081/reumatismo.2010.215

  1371

  PDF: 885

• PO:21:018 | The role of rheumatologists in the diagnosis and monitoring of Whipple's disease Mariangela Salvato¹, Alessandro Giollo¹, Marco Cola², Francesca Frizzera¹, Kiren Khalid¹, Lorenzo Di Luozzo¹, Annamaria Cattelan², Andrea Doria¹ | ¹UOC Reumatologia, AOUI Padova, Italy; ²UOC Malattie infettive, AOUI Padova, Italy

  Società Italiana di Reumatologia

  18-03-2026

  https://doi.org/10.4081/reumatismo.2025.2343

  73
• 

  The Italian Society of Rheumatology clinical practice guidelines for the management of large vessel vasculitis

  N. Ughi, R. Padoan, C. Crotti, S. Sciascia, G. Carrara, A. Zanetti, D. Rozza, S. Monti, D. Camellino, F. Muratore, G. Emmi, L. Quartuccio, S. Morbelli, K. El Aoufy, S. Tonolo, R. Caporali, S. De Vita, C. Salvarani, M.A. Cimmino

  07-02-2022

  https://doi.org/10.4081/reumatismo.2021.1470

  10232

  PDF: 2331

• Pure analgesics in a rheumatological outpatient clinic

  T. Maio, P. Trezzi, M.A. Cimmino

  116-121

  https://doi.org/10.4081/reumatismo.2001.116

  958

  PDF: 702

• PO:07:111 | Worsening of patient-reported outcomes is an early predictor of disease flare in patients with rheumatoid arthritis in course of treatment with conventional synthetic disease modifying anti-rheumatic drugs Ludovico De Stefano^1|2, Federica Sabatelli^1|2, Clelia Zampaglione^1|2, Blerina Xoxi², Antonio Manzo^1|2, Carlomaurizio Montecucco^1|2, Serena Bugatti^1|2. | ¹Department of Internal Medicine and Therapeutics, University of Pavia, Pavia, Italy; ²Division of Rheumatology, IRCCS Policlinico San Matteo Foundation, Pavia, Italy.

  Società Italiana di Reumatologia

  25-11-2025

  https://doi.org/10.4081/reumatismo.2025.2022

  185